Final results of a meta-analysis testing HER2 and topoisomerase II alpha genes as predictors of incremental benefit from anthracyclines in breast cancer. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Di Leo, A
  • Desmedt, C
  • Bartlett, JA
  • Ejlertsen, B
  • Pritchard, Kathleen
  • Poole, CJ
  • Larsimont, D
  • Tanner, M
  • Plette, F
  • Buyse, ME

publication date

  • May 20, 2010